Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema-Reference-Cited by-同舟云学术

Five-Year Outcomes of Ranibizumab With Prompt or Deferred Laser Versus Laser or Triamcinolone Plus Deferred Ranibizumab for Diabetic Macular Edema

Published:2016-04 Issue: Volume:164 Page:57-68
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Bressler Susan B.,Glassman Adam R.,Almukhtar Talat,Bressler Neil M.,Ferris Frederick L.,Googe Joseph M.,Gupta Shailesh K.,Jampol Lee M.,Melia Michele,Wells John A.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference5 articles.

1. Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema;Elman;Ophthalmology,2011

2. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results;Elman;Ophthalmology,2015

3. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema;Diabetic Retinopathy Clinical Research Network;Ophthalmology,2010

4. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE;Brown;Ophthalmology,2013

5. Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE Extension Study;Schmidt-Erfurth;Ophthalmology,2014

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravitreal Antiangiogenic Treatment for Diabetic Retinopathy: A Mexican Real-Life Scenario Experience;Life;2024-08-02

2. Global research trends and future directions in diabetic macular edema research: A bibliometric and visualized analysis;Medicine;2024-06-21

3. Diabetic Disease of the Eye in Canada: Consensus Statements from a Retina Specialist Working Group;Ophthalmology and Therapy;2024-03-23

4. Sustained Disease Control in DME Patients upon Treatment Cessation with Brolucizumab;Journal of Clinical Medicine;2024-03-07

5. Treatments for diabetic retinopathy and diabetic macular edema in pipeline;Therapeutic Targets for Diabetic Retinopathy;2024